Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

People who use drugs with anticholinergic effects, including certain antidepressants, drugs for urinary incontinence and common antihistamines, are at higher risk of developing cardiovascular disease.

Originally designed for diabetes and obesity, GLP-1-based drugs may also blunt the brain's reward signals that drive alcohol, ...

A study of 600,000+ veterans found GLP-1 drugs like Ozempic reduced substance-related deaths by 50% across alcohol, opioids, cocaine, nicotine, and cannabis — making them the first medication class to ...

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

A study of more than 600,000 veterans found that GLP-1 drugs — originally designed for diabetes and weight loss — cut ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who ...

Here's what happens to your heart, liver, skin, and more.

A large new study from the United Kingdom has raised fresh concerns about a drug often used to calm severe agitation in people with dementia. The research found that the medication risperidone may ...